Key Information
This over-the-counter medication combines:
- Guaifenesin - an expectorant intended to loosen mucus
- Dextromethorphan (DM) - a cough suppressant
The combination product is manufactured by Reckitt Benckiser and marketed as Mucinex DM 1, 2.
Clinical Context
While this combination is widely available and commonly used, the evidence for its effectiveness is mixed:
For Dextromethorphan:
- Guidelines support its use as a cough suppressant for acute viral cough 3
- Maximum cough reflex suppression occurs at 60 mg doses 3
- Generally regarded as safer than codeine-based alternatives with fewer adverse effects 3
For Guaifenesin:
- Evidence of effectiveness is limited and inconsistent 4
- Studies show it was ineffective in patients with chronic bronchitis 4
- Some case reports suggest benefit in specific COPD patients 1, though systematic evidence is lacking
- Medical consultants have historically not been impressed by guaifenesin's effectiveness 2
Common Pitfall: Many over-the-counter preparations contain subtherapeutic doses of dextromethorphan. When recommending this combination, verify the actual dosing, as therapeutic benefit requires adequate dextromethorphan dosing (up to 60 mg) 3.